Virtonomy enables medical studies on virtual patients: Using database-driven software, tests or studies in the approval process for medical devices can be simulated on the computer. This should make the approval process cheaper and faster. By solving the problem, the company founded at the end of 2019 by Simon Sonntag and Wen-Yang Chu Startups Animal testing and subsequent human trials should also be replaced. The fresh capital will be used for further technological development of the product, the recruitment of additional employees, and the expansion of the database.
Virtonomy wants to create not only economic but also social benefits
Simulation solutions have been in use for some time in other industries, such as the automotive industry. They enable more testing in less time and with more iterations. The ten-person team is building virtual, customizable anatomies of human bodies. Manufacturers of medical devices, such as implants, can use the software to test their technologies on virtual patients during all development phases – from the concept phase through preclinical evaluation to long-term monitoring in widespread patient use.
“From the outset, we wanted to develop a solution that would not only have economic but also social benefits,”
says Simon Sunday, CEO of Virtonomy.
"The development of new medical technology products remains particularly time- and cost-intensive. Therefore, even young companies like ours that want to make a difference in this industry rely on strong capital support during the start-up and growth phases. We are therefore delighted to have won over a consortium of industry-experienced investors, including Dieter von Holtzbrinck Ventures, Bayern Kapital, Initiative for Industrial Innovators, and Plug and Play, to our vision."
